Neman-Ebrahim Yousha
CIK 2071642 · Chief Clinical Officer · last filed 2026-04-24
Neman-Ebrahim Yousha is a Chief Clinical Officer who has filed 3 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing shows the insider bought $2.4K of NTHI on Apr 24, 2026. Across all open-market trades the lifetime net is +$9.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $595.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$595.6K
1
3
$9.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NTHI | Chief Clinical Officer | 134,760 | $4.42 | $595.6K | $9.8K | 3 | 2026-04-24 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-24 | NTHI | Buy (P) | +500 | $2.4K | EDGAR |
| 2025-11-24 | NTHI | Buy (P) | +1,100 | $7.4K | EDGAR |
| 2025-06-09 | NTHI | Grant (A) | +133,000 | $0 | EDGAR |